Chemotherapy and granulocyte-colony stimulating factor for non-Hodgkin's lymphoma of the head and neck

Acta Oto-Laryngologica, Supplement

Volumn , Issue 525, 1996, Pages 129-134

  Tsuge, Isato ^a   Suzuki, Kenji ^b   Moribe, Kazuho ^b   Motai, Hisato ^a   Kimura, Toshio ^c   Umeda, Keiko ^c   Kobayashi, Takehiro ^d   Yokota, Akira ^e   Hondo, Jun ^f   Baba, Shunkichi ^b  

^a Department of Rehabilitation Medicine   (Japan)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^c Ichinomiya City Hospital   (Japan)

^d Kasugai City Hospital   (Japan)

^e Department of Surgery   (Japan)

^f NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

Author keywords

Bone marrow suppression; Combination therapy; Lymphom in the otorhinolaryngology field

Indexed keywords

CYCLOPHOSPHAMIDE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; PIRARUBICIN; PREDNISOLONE; VINCRISTINE;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CLINICAL ARTICLE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHODGKIN LYMPHOMA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; AGRANULOCYTOSIS; DRUG COMBINATION; DRUG EFFECT; DRUG THERAPY; GRANULOCYTE; HEAD AND NECK TUMOR; LEUKOCYTE; LEUKOPENIA; MIDDLE AGED; NEUTROPENIA; NEUTROPHIL; PATHOLOGY;

AGED; AGRANULOCYTOSIS; DRUG THERAPY; DRUG THERAPY, COMBINATION; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTES; HEAD AND NECK NEOPLASMS; HUMANS; LEUKOCYTES; LEUKOPENIA; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEUTROPENIA; NEUTROPHILS;

EID: 0029658783     PISSN: 03655237     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Oyama A, Ota K. A double-blind, cross-over clinical trial of recombinant human G-CSF on neutropenia induced by chemotherapy for non-Hodgkin's lymphoma. J Jpn Soc Cancer Ther 1990; 25: 2533-48 (in Japanese).
2. Oyama A, Ota K. Clinical effect of recombinant human G-CSF on neutropenia induced by chemotherapy for non-Hodgkin's lymphoma. J Jpn Soc Cancer Ther 1990; 25: 1619-34 (in Japanese).
3. Connors JM, Klimo P, Fairey RN. Brief chemotherapy and involved field radiation therapy for limited-stage, histologically aggressive lymphoma. Ann Intern Med 1987; 107: 25-30.
4. McKelvey. Hydroxyl aunomycin (adriamycin) combination chemotherapy in malignant lymphoma. Cancer 1976; 38: 1484-93.
5. Suzuki K, Baba S, Shimada J. Combined immuno-radio-chemotherapy for head and neck non-Hodgkin's lymphoma. Jpn J Cancer Chemother 1990; 15: 3261-5 (in Japanese).
6. Suzuki K, Baba S, Motai H. Analysis of patient with non-Hodgkin's lymphoma resistant to therapy. Pract Otol (Kyoto) 1990; 83: 443-8 (in Japanese).
7. Tsuge I, Suzuki K, Itaya S, Baba S. A case resistant to VEMP therapy benefitted from MEC-LV therapy. Otologia Fukuoka 1991; 37: 150-2 (in Japanese).
8. Kato M, Shikoshi K, Takada M, Umeda M, Tsukahara T, Shirai T. Neutrophil function during treatment with granulocyte colony-stimulating factor (G-CSF) in the elderly with non-Hodgkin's lymphoma: including two patients accompanied with interstitial pneumonitis during the treatment with G-CSF. Jpn J Geriat 1993; 30: 953-7.